Procoralan

Country: Evrópusambandið

Tungumál: enska

Heimild: EMA (European Medicines Agency)

Kauptu það núna

Vara einkenni Vara einkenni (SPC)
12-10-2021
Opinber matsskýrsla Opinber matsskýrsla (PAR)
26-02-2019

Virkt innihaldsefni:

ivabradine hydrochloride

Fáanlegur frá:

Les Laboratoires Servier

ATC númer:

C01EB17

INN (Alþjóðlegt nafn):

ivabradine

Meðferðarhópur:

Cardiac therapy

Lækningarsvæði:

Angina Pectoris; Heart Failure

Ábendingar:

Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated :in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.Treatment of chronic heart failure Ivabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Vörulýsing:

Revision: 22

Leyfisstaða:

Authorised

Leyfisdagur:

2005-10-25

Upplýsingar fylgiseðill

                                28
B. PACKAGE LEAFLET
29
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
PROCORALAN 5
MG FILM-COATED TABLETS
PROCORALAN 7.5
MG FILM-COATED TABLETS
ivabradine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Procoralan is and what it is used for
2.
What you need to know before you take Procoralan
3.
How to take Procoralan
4.
Possible side effects
5
How to store Procoralan
6.
Contents of the pack and other information
1.
WHAT PROCORALAN IS AND WHAT IT IS USED FOR
Procoralan (ivabradine) is a heart medicine used to treat:
-
Symptomatic stable angina pectoris (which causes chest pain) in adult
patients whose heart rate is
over or equal to 70 beats per minute. It is used in adult patients who
do not tolerate or cannot take
heart medicines called beta-blockers. It is also used in combination
with beta-blockers in adult
patients whose condition is not fully controlled with a beta-blocker.
-
Chronic heart failure in adult patients whose heart rate is over or
equal to 75 beats per minute. It is
used in combination with standard therapy, including beta-blocker
therapy or when beta-blockers
are contraindicated or not tolerated.
About stable angina pectoris (usually referred to as “angina”):
Stable angina is a heart disease which happens when the heart does not
receive enough oxygen. The
most common symptom of angina is chest pain or discomfort.
About chronic heart failure :
Chronic heart failure is a heart disease which happens when your heart
cannot pump enough blood to
the rest of your body. The most c
                                
                                Lestu allt skjalið
                                
                            

Vara einkenni

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Procoralan 5 mg film-coated tablets
Procoralan 7.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Procoralan 5 mg film-coated tablets
Each film-coated tablet contains 5 mg ivabradine (as hydrochloride).
_Excipient with known effect: _
Each film-coated tablet contains 63.91 mg lactose monohydrate.
Procoralan 7.5 mg film-coated tablets
Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride).
_Excipient with known effect: _
Each film-coated tablet contains 61.215 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Procoralan 5 mg film-coated tablets
Salmon-coloured, oblong, film-coated tablet scored on both sides,
engraved with “5” on one face
and
on the other face.
The tablet can be divided into equal doses.
Procoralan 7.5 mg film-coated tablets
Salmon-coloured, triangular, film-coated tablet engraved with
“7.5” on one face and
on the other
face.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Symptomatic treatment of chronic stable angina pectoris
Ivabradine is indicated for the symptomatic treatment of chronic
stable angina pectoris in coronary
artery disease adults with normal sinus rhythm and heart rate ≥ 70
bpm. Ivabradine is indicated:
-
in adults unable to tolerate or with a contraindication to the use of
beta-blockers
-
or in combination with beta-blockers in patients inadequately
controlled with an optimal beta-
blocker dose.
3
Treatment of chronic heart failure
Ivabradine is indicated in chronic heart failure NYHA II to IV class
with systolic dysfunction, in adult
patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in
combination with standard therapy
including beta-blocker therapy or when beta-blocker therapy is
contraindicated or not tolerated (see
section 5.1).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Symptomatic treatment of chronic stable angina pectoris _
It is recommended that the deci
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill búlgarska 12-10-2021
Vara einkenni Vara einkenni búlgarska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla búlgarska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill spænska 12-10-2021
Vara einkenni Vara einkenni spænska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla spænska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill tékkneska 12-10-2021
Vara einkenni Vara einkenni tékkneska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla tékkneska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill danska 12-10-2021
Vara einkenni Vara einkenni danska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla danska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 12-10-2021
Vara einkenni Vara einkenni þýska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla þýska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill eistneska 12-10-2021
Vara einkenni Vara einkenni eistneska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla eistneska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill gríska 12-10-2021
Vara einkenni Vara einkenni gríska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla gríska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 12-10-2021
Vara einkenni Vara einkenni franska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla franska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ítalska 12-10-2021
Vara einkenni Vara einkenni ítalska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla ítalska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill lettneska 12-10-2021
Vara einkenni Vara einkenni lettneska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla lettneska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill litháíska 12-10-2021
Vara einkenni Vara einkenni litháíska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla litháíska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ungverska 12-10-2021
Vara einkenni Vara einkenni ungverska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla ungverska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill maltneska 12-10-2021
Vara einkenni Vara einkenni maltneska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla maltneska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 12-10-2021
Vara einkenni Vara einkenni hollenska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla hollenska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill pólska 12-10-2021
Vara einkenni Vara einkenni pólska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla pólska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill portúgalska 12-10-2021
Vara einkenni Vara einkenni portúgalska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla portúgalska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill rúmenska 12-10-2021
Vara einkenni Vara einkenni rúmenska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla rúmenska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvakíska 12-10-2021
Vara einkenni Vara einkenni slóvakíska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla slóvakíska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvenska 12-10-2021
Vara einkenni Vara einkenni slóvenska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla slóvenska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill finnska 12-10-2021
Vara einkenni Vara einkenni finnska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla finnska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill sænska 12-10-2021
Vara einkenni Vara einkenni sænska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla sænska 26-02-2019
Upplýsingar fylgiseðill Upplýsingar fylgiseðill norska 12-10-2021
Vara einkenni Vara einkenni norska 12-10-2021
Upplýsingar fylgiseðill Upplýsingar fylgiseðill íslenska 12-10-2021
Vara einkenni Vara einkenni íslenska 12-10-2021
Upplýsingar fylgiseðill Upplýsingar fylgiseðill króatíska 12-10-2021
Vara einkenni Vara einkenni króatíska 12-10-2021
Opinber matsskýrsla Opinber matsskýrsla króatíska 26-02-2019

Leitaðu viðvaranir sem tengjast þessari vöru

Skoða skjalasögu